Results
1 -
6 of
6Current Status of the Development of HIV Protease Inhibitors and Their Clinical Potential, Clinical Immunotherapeutics Quantitative structure-activity relationship by CoMFA for cyclic urea and nonpeptide-cyclic cyanoguanidine derivatives on wild type and mutant HIV-1 protease, Journal of Molecular Modeling R&D news from the 1st IAS Conference on HIV Pathogenesis and Treatment, Inpharma Weekly The cyclic urea protease inhibitor DMP-450 appears effective in the treatment of HIV infection,, Inpharma Weekly